Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

25.54
Delayed Data
As of Sep 29
 +0.10 / +0.39%
Today’s Change
13.73
Today|||52-Week Range
37.75
+50.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$678.8M

Company Description

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Contact Information

Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive
San Diego California 92121
P:(858) 900-2660
Investor Relations:
(858) 900-2682

Employees

Shareholders

Mutual fund holders61.12%
Other institutional22.90%
Individual stakeholders14.25%

Top Executives

Joseph E. PaynePresident, Chief Executive Officer & Director
Padmanabh ChivukulaSecretary, Chief Operating & Scientific Officer
Andrew H. SassineChief Financial Officer & Director
Dushyant B. VarshneyChief Technology Office & Executive VP
Kevin T. SkolChief Business Officer